The Global Automated Breast Ultrasound Systems Market was valued at US$ 236.5 million in 2015, according to a new report by published by Coherent Market Insights. Increasing incidence of breast cancer is propelling market growth for automated breast ultrasound systems worldwide.
Regulatory approval from the U.S. Food & Drug Administration (FDA) for using automated breast ultrasound systems (ABUS) as an adjunct with mammography in screening women with dense breasts has augmented market growth. ABUS with better sensitivity enables screening of small tumors in women with dense breasts. Furthermore, use of ABUS in preoperative evaluation is projected to be one of the major driving factors for these systems. Providers need to focus on reducing costs, while rate of false positives can be significantly reduced through proper training of device operators. GE Healthcare offers FDA-required onsite training to technologists and radiologists for using the ABUS system. Other market players also need to practice customer engagement activities and provide additional services to their customers in order to sustain the market competition.
To know the latest trends and insights prevalent in this market, click the link below:
Advancements in automated breast ultrasound systems (ABUS) has propelled demand for handheld ultrasound system (HHUS), which is expected to drive market growth over the forecast period. Recent past has witnessed high demand for ABUS from physician to improve efficiency of diagnosis, owing to various features offered by ABUS such as high quality 3D images, reduced screening time, and the ability to screen dense breast tissues and small tumors effectively.
In 2014, the U.S. Food and Drug Administration (FDA) approved GE’s Invenia ABUS for using it as a supplementary product with mammogram in breast cancer diagnosis, which has increased the adoption of ABUS among hospitals for screening of breasts cancer. Furthermore, high prevalence of breast cancer is a major factor driving growth of the market. According to the American Cancer Society, in 2016, an estimated 246,660 new cases of invasive breast cancer were reported in the U.S. As per the estimates of the Philippine Obstetrical and Gynecological Society, the highest incidence of breast cancers were reported in Philippines, with a mammoth increase of 589% in breast cancer cases reported over a period of 30-years (1980 - 2010).
Furthermore, high adoption of ABUS is accelerating preoperative evaluation of tumors. Various studies are being conducted to establish the benefits of using ABUS in preoperative application. In January 2016, a trial was conducted by the University of Zurich for preoperative evaluation of breast cancer using ABUS in women newly diagnosed with breast cancer. Favorable outcomes of such studies are expected to further expand the scope for ABUS in preoperative evaluation, which in turn is expected to drive growth of the market.
ABUS is majorly adopted in developed economies such as the U.S., Australia, Japan, the U.K., and Canada. However, high costs of installing ABUS and low number of women opting for early breast screening is restraining growth of the market in emerging economies.
Key takeaways of the market are:
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Email: [email protected]
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.